Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent NonHodgkin Lymphoma: 4-Year Follow-up from the Phase 2 ZUMA-5 Trial
Sattva S. Neelapu,Julio C. Chavez,Alison R. Sehgal,Narendranath Epperla,Matthew L. Ulrickson,Emmanuel Bachy,Pashna N. Munshi,Carla Casulo,David G. Maloney,Sven de Vos,Ran Reshef,Lori A. Leslie,Olalekan O. Oluwole,Ibrahim Yakoub-Agha,Rashmi Khanal,Joseph D. Rosenblatt,Weixin Peng,Christine Lui, Jacob Wulff,Rhine R. Shen,Soumya Poddar, Andrew Lee,Harry Miao,Olga Nikolajeva,Caron A. Jacobson BLOOD（2023）
AI 理解论文
溯源树
样例
